Niger
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
11.61 (8.18 - 16.22) | 2015 | Modelled | WHO |
8.61 (14.38 - 16.65) | 2013 | Modelled | Schweitzer et al, 2015 |
8.73 (8.43 - 9.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
10.06 (9.78 - 10.35) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.47 (10.17 - 10.81) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.58 (10.31 - 10.89) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.7 (10.35 - 11.05) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.94 (10.58 - 11.30) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.36 (10.99 - 11.75) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.84 (11.43 - 12.25) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.24 (11.78 - 12.69) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.43 (11.95 - 12.93) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.64 (12.17 - 13.13) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
13.06 (12.55 - 13.61) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
13.57 (12.99 - 14.16) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
14 (13.34 - 14.65) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.21 (13.47 - 14.91) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.27 (13.59 - 14.92) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.32 (13.69 - 14.95) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.37 (13.74 - 15.03) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.43 (13.79 - 15.11) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.5 (13.81 - 15.23) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.58 (13.95 - 15.25) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.68 (14.08 - 15.29) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.78 (14.18 - 15.40) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.89 (14.25 - 15.49) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
14.99 (14.31 - 15.60) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
15.08 (14.42 - 15.66) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
15.18 (14.55 - 15.76) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
15.28 (14.66 - 15.85) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
15.39 (14.77 - 15.98) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
15.49 (14.86 - 16.11) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.27 (8.98 - 9.56) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
6.01 (3.77 - 9.44) | 2015 | Modelled | WHO |
3.29 (2.77 - 3.72) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
3.55 (3.02 - 4.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.68 (3.23 - 4.12) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.8 (3.33 - 4.27) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.95 (3.45 - 4.45) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.05 (3.51 - 4.56) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.07 (3.53 - 4.61) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.08 (3.53 - 4.60) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.09 (3.55 - 4.58) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.1 (3.55 - 4.59) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.13 (3.55 - 4.69) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.9 (4.21 - 5.53) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.69 (5.79 - 7.53) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.82 (7.61 - 9.92) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.62 (9.10 - 12.05) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.41 (9.64 - 13.10) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.45 (9.79 - 13.03) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.47 (9.90 - 12.99) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.47 (9.96 - 13.06) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.48 (9.93 - 13.13) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.49 (9.79 - 13.33) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.54 (10.02 - 13.15) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.63 (10.13 - 13.13) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.75 (10.23 - 13.12) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.86 (10.26 - 13.26) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.94 (10.25 - 13.34) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
12 (10.40 - 13.32) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.07 (10.57 - 13.35) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.15 (10.67 - 13.45) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.23 (10.73 - 13.58) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
12.3 (10.77 - 13.73) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.44 (2.63 - 4.50) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,034,140 (1,962,920 - 2,102,530) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2,103,710 (2,037,550 - 2,166,820) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,196,020 (2,135,370 - 2,254,760) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,201,050 (2,139,930 - 2,270,340) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,143,660 (2,088,660 - 2,203,960) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,088,290 (2,023,070 - 2,158,120) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,056,920 (1,990,950 - 2,124,970) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,058,610 (1,991,400 - 2,129,420) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,066,720 (1,996,040 - 2,140,400) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,057,900 (1,982,330 - 2,134,920) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,012,820 (1,935,350 - 2,093,870) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,968,670 (1,896,870 - 2,045,720) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,956,770 (1,880,540 - 2,037,170) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,953,720 (1,870,330 - 2,041,320) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,938,810 (1,844,910 - 2,029,490) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,894,370 (1,794,180 - 1,987,290) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,831,350 (1,742,980 - 1,916,190) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,771,490 (1,690,330 - 1,851,410) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,714,400 (1,639,060 - 1,792,720) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,659,780 (1,586,680 - 1,737,990) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,607,580 (1,531,340 - 1,691,000) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,558,340 (1,492,030 - 1,631,990) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,512,810 (1,451,060 - 1,578,050) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,469,950 (1,409,420 - 1,531,260) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,429,160 (1,367,000 - 1,487,560) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,390,190 (1,324,930 - 1,447,990) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,352,880 (1,293,380 - 1,406,260) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,317,930 (1,263,520 - 1,367,460) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,285,100 (1,234,370 - 1,334,260) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,254,270 (1,203,170 - 1,304,130) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,225,090 (1,174,840 - 1,275,090) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
7.25 (4.55 - 10.80) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
11.65 (8.20 - 15.95) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.47 (8.03 - 15.70) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.44 (7.99 - 15.78) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.42 (7.94 - 15.83) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.27 (7.76 - 15.60) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.22 (7.71 - 15.45) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.93 (7.39 - 15.19) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.94 (7.37 - 15.26) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.91 (7.28 - 15.24) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.84 (7.27 - 15.14) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.78 (7.23 - 15.16) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.83 (7.33 - 15.12) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.83 (7.39 - 15.17) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.91 (7.51 - 15.24) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.7 (7.20 - 15) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.72 (7.23 - 15.08) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.34 (6.87 - 14.63) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.99 (6.67 - 14.35) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.47 (6.26 - 13.59) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.17 (6.04 - 12.97) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.92 (5.79 - 12.77) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.62 (5.60 - 12.58) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.44 (5.54 - 12.46) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.37 (5.44 - 12.43) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.36 (5.39 - 12.39) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.26 (5.42 - 12.27) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.26 (5.35 - 12.24) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.94 (5.13 - 11.71) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.24 (5.45 - 12.30) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.25 (4.55 - 10.78) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,029 | 2016 | Modelled | WHO |
935 (658 - 1,279) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
949 (665 - 1,299) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
977 (682 - 1,347) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,007 (700 - 1,396) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,027 (708 - 1,422) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,057 (727 - 1,456) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,144 (763 - 1,598) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,066 (721 - 1,482) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,106 (745 - 1,543) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,178 (790 - 1,646) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,216 (815 - 1,711) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,316 (899 - 1,844) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,268 (858 - 1,770) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,376 (948 - 1,922) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,402 (944 - 1,965) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,463 (971 - 2,068) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,459 (983 - 2,053) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,467 (980 - 2,108) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,446 (956 - 2,076) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,478 (960 - 2,156) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,455 (958 - 2,057) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,471 (955 - 2,106) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,503 (986 - 2,219) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,549 (1,006 - 2,298) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,606 (1,036 - 2,380) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,714 (1,125 - 2,546) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,649 (1,067 - 2,443) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,777 (1,175 - 2,652) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,779 (1,150 - 2,623) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,688 (1,060 - 2,511) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,688 (1,060 - 2,511) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
81 | 2019 | Survey/reported | WHO/UNICEF |
81 | 2020 | Survey/reported | WHO/UNICEF |
82 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
2.82 (2.24 - 3.53) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.83 (2.26 - 3.56) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.83 (2.26 - 3.57) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.82 (2.25 - 3.56) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.82 (2.25 - 3.57) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.83 (2.25 - 3.59) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.85 (2.27 - 3.61) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.87 (2.30 - 3.65) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.9 (2.32 - 3.68) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.92 (2.33 - 3.71) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.95 (2.35 - 3.74) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.97 (2.37 - 3.75) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
3 (2.40 - 3.80) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.03 (2.42 - 3.83) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.05 (2.44 - 3.86) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.08 (2.46 - 3.90) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.1 (2.48 - 3.91) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.12 (2.50 - 3.95) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.15 (2.52 - 3.99) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.17 (2.53 - 4.02) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.19 (2.55 - 4.03) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.21 (2.58 - 4.06) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.23 (2.59 - 4.05) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.24 (2.61 - 4.07) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.26 (2.61 - 4.11) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.28 (2.62 - 4.12) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.29 (2.62 - 4.14) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.31 (2.63 - 4.16) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.33 (2.64 - 4.19) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.35 (2.64 - 4.23) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.73 (2.16 - 3.42) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.42 (1.17 - 1.60) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
264,473 (208,893 - 334,118) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
271,268 (215,197 - 342,252) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
278,459 (221,155 - 350,115) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
286,049 (228,207 - 359,677) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
294,043 (235,487 - 370,075) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
302,595 (242,961 - 381,319) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
311,493 (250,514 - 391,028) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
320,948 (257,738 - 402,144) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
330,797 (265,792 - 417,524) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
340,955 (272,439 - 430,068) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
351,495 (279,753 - 446,388) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
362,004 (289,895 - 458,096) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
372,666 (298,248 - 470,373) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
383,532 (306,550 - 483,957) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
394,775 (315,699 - 500,412) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
406,713 (324,140 - 515,867) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
419,072 (334,097 - 529,934) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
431,959 (344,309 - 545,514) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
445,326 (355,010 - 562,077) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
459,190 (366,119 - 581,775) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
473,606 (376,676 - 600,160) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
487,658 (389,731 - 618,977) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
501,389 (401,875 - 637,123) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
515,599 (412,178 - 654,393) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
531,323 (424,214 - 675,656) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
549,796 (438,035 - 695,452) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
571,321 (454,682 - 720,697) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
594,324 (473,461 - 751,515) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
617,288 (494,232 - 778,585) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
640,487 (507,767 - 802,449) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
635,075 (503,390 - 796,387) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
69,600 (57,100 - 78,100) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
1.01 (0.61 - 1.65) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
1.42 (0.88 - 2.18) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.39 (0.87 - 2.14) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.38 (0.86 - 2.11) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.37 (0.87 - 2.08) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.35 (0.86 - 2.04) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.34 (0.86 - 2.03) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.3 (0.83 - 1.92) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.3 (0.83 - 1.96) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.29 (0.82 - 1.90) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.28 (0.82 - 1.90) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.27 (0.80 - 1.89) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (0.78 - 1.84) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.26 (0.81 - 1.85) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.23 (0.78 - 1.83) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.75 - 1.77) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.75 - 1.75) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.15 (0.73 - 1.72) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.12 (0.70 - 1.69) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.07 (0.65 - 1.65) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.61 - 1.56) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.04 (0.63 - 1.60) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.59 - 1.52) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.95 (0.57 - 1.47) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.94 (0.56 - 1.46) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.93 (0.56 - 1.47) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.92 (0.55 - 1.46) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.94 (0.56 - 1.49) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.96 (0.58 - 1.57) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.60 - 1.59) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.61 - 1.65) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
459 | 2016 | Modelled | WHO |
236 (142 - 383) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
236 (142 - 383) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
218 (134 - 355) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
206 (126 - 338) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
194 (117 - 309) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
183 (110 - 292) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
179 (107 - 282) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
173 (104 - 270) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
169 (101 - 261) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
168 (101 - 261) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
167 (100 - 257) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
165 (100 - 254) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
163 (99 - 251) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
164 (103 - 248) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
162 (103 - 243) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
162 (103 - 238) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
156 (98 - 232) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
155 (98 - 230) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
150 (95 - 224) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
147 (94 - 216) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
143 (91 - 213) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
139 (89 - 207) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
135 (86 - 199) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
131 (84 - 194) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
127 (81 - 191) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
126 (81 - 191) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
123 (78 - 186) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
121 (77 - 183) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
118 (73 - 180) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
115 (72 - 177) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
114 (70 - 175) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,688
2019
(1,060 - 2,511)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
236
2019
(142 - 383)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
3.44
(%)
2020, latest modelled
(2.63 - 4.50(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines